Consenso de expertos sobre la enfermedad pulmonar intersticial asociada a enfermedades autoinmunes sistémicas. Resumen ejecutivo

IF 1.7 4区医学 Q2 MEDICINE, GENERAL & INTERNAL

Revista clinica espanola Pub Date : 2025-08-01 DOI:10.1016/j.rce.2025.502326

A. González-García , M. Akasbi , P. Brito-Zerón , J.L. Callejas , I. Cusacovich , F. Jiménez Segovia , M. Martín Cascón , S. Prieto-González , L. Sáez Comet , C.P. Simeón , R. Solans Laque , J.S. García Morillo , en representación del grupo de Enfermedades Autoinmunes Sistémicas (GEAS) de la Sociedad Española de Medicina Interna (SEMI)

{"title":"Consenso de expertos sobre la enfermedad pulmonar intersticial asociada a enfermedades autoinmunes sistémicas. Resumen ejecutivo","authors":"A. González-García , M. Akasbi , P. Brito-Zerón , J.L. Callejas , I. Cusacovich , F. Jiménez Segovia , M. Martín Cascón , S. Prieto-González , L. Sáez Comet , C.P. Simeón , R. Solans Laque , J.S. García Morillo , en representación del grupo de Enfermedades Autoinmunes Sistémicas (GEAS) de la Sociedad Española de Medicina Interna (SEMI)","doi":"10.1016/j.rce.2025.502326","DOIUrl":null,"url":null,"abstract":"<div><div>Interstitial lung disease is a frequent and potentially fatal manifestation of systemic autoimmune diseases. Early screening, diagnosis, and treatment with immunomodulators, and in some cases, antifibrotics, as well as appropriate follow-up, are essential to improving patients’ quality of life and survival. The complexity of these diseases and the limited robust evidence to guide clinical decision-making lead to significant variability in management guidelines. In this article, a group of experts in systemic autoimmune diseases has developed recommendations for the screening, diagnosis, treatment, and follow-up of interstitial lung disease, considering the latest evidence, their clinical experience, and the results of a survey conducted among specialists. The diseases included are systemic sclerosis, Sjögren's disease, idiopathic inflammatory myopathy, ANCA-associated vasculitis, sarcoidosis and systemic lupus erythematosus.</div></div>","PeriodicalId":21223,"journal":{"name":"Revista clinica espanola","volume":"225 7","pages":"Article 502326"},"PeriodicalIF":1.7000,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista clinica espanola","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S001425652500089X","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}

引用次数: 0

Abstract

Interstitial lung disease is a frequent and potentially fatal manifestation of systemic autoimmune diseases. Early screening, diagnosis, and treatment with immunomodulators, and in some cases, antifibrotics, as well as appropriate follow-up, are essential to improving patients’ quality of life and survival. The complexity of these diseases and the limited robust evidence to guide clinical decision-making lead to significant variability in management guidelines. In this article, a group of experts in systemic autoimmune diseases has developed recommendations for the screening, diagnosis, treatment, and follow-up of interstitial lung disease, considering the latest evidence, their clinical experience, and the results of a survey conducted among specialists. The diseases included are systemic sclerosis, Sjögren's disease, idiopathic inflammatory myopathy, ANCA-associated vasculitis, sarcoidosis and systemic lupus erythematosus.

查看原文本刊更多论文

关于与全身性自身免疫性疾病相关的间质性肺病的专家共识。执行摘要

间质性肺疾病是一种常见且可能致命的系统性自身免疫性疾病。早期筛查、诊断和免疫调节剂治疗，在某些情况下使用抗纤维化药物，以及适当的随访，对于改善患者的生活质量和生存率至关重要。这些疾病的复杂性和指导临床决策的有限有力证据导致管理指南的显著差异。在这篇文章中，一组系统性自身免疫性疾病的专家考虑到最新的证据、他们的临床经验和专家调查的结果，对间质性肺疾病的筛查、诊断、治疗和随访提出了建议。这些疾病包括系统性硬化症、Sjögren病、特发性炎性肌病、anca相关血管炎、结节病和系统性红斑狼疮。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Revista clinica espanola 医学-医学：内科

CiteScore

4.40

自引率

6.90%

发文量

审稿时长

28 days

期刊介绍： Revista Clínica Española published its first issue in 1940 and is the body of expression of the Spanish Society of Internal Medicine (SEMI). The journal fully endorses the goals of updating knowledge and facilitating the acquisition of key developments in internal medicine applied to clinical practice. Revista Clínica Española is subject to a thorough double blind review of the received articles written in Spanish or English. Nine issues are published each year, including mostly originals, reviews and consensus documents.